tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Midday Fly By: Nvidia invests in Synopsys, U.S. strikes pharma deal with UK
PremiumThe FlyMidday Fly By: Nvidia invests in Synopsys, U.S. strikes pharma deal with UK
1M ago
Sionna downgraded to Underperform from Sector Perform at RBC Capital
Premium
The Fly
Sionna downgraded to Underperform from Sector Perform at RBC Capital
1M ago
BTIG Assigns Buy Rating to Sionna Therapeutics, Citing Innovative Cystic Fibrosis Therapies and Strong Market Potential
Premium
Ratings
BTIG Assigns Buy Rating to Sionna Therapeutics, Citing Innovative Cystic Fibrosis Therapies and Strong Market Potential
2M ago
Sionna Therapeutics expects cash to fund operations into 2028
PremiumThe FlySionna Therapeutics expects cash to fund operations into 2028
2M ago
Sionna Therapeutics Advances Cystic Fibrosis Treatment with New Study
Premium
Company Announcements
Sionna Therapeutics Advances Cystic Fibrosis Treatment with New Study
2M ago
Sionna Therapeutics Advances Phase 1 Study for Cystic Fibrosis Treatment
Premium
Company Announcements
Sionna Therapeutics Advances Phase 1 Study for Cystic Fibrosis Treatment
2M ago
Buy Rating for Sionna Therapeutics: Innovative Cystic Fibrosis Treatments with Promising Clinical Trials
PremiumRatingsBuy Rating for Sionna Therapeutics: Innovative Cystic Fibrosis Treatments with Promising Clinical Trials
4M ago
Short Report: Frontier Group short positioning continues gaining altitude
Premium
The Fly
Short Report: Frontier Group short positioning continues gaining altitude
4M ago
Sionna Therapeutics initiated with a Sector Perform at RBC Capital
Premium
The Fly
Sionna Therapeutics initiated with a Sector Perform at RBC Capital
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100